Zacks Investment Research on MSN1d
Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More
It was a busy week in the biotech sector, marked by significant regulatory and pipeline updates. Among these, shares of ...
PMLive1d
BMS receives positive CHMP opinion for perioperative Opdivo regimen in lung cancer
Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) perioperative treatment regimen has been recommended by the European Medicines Agency’s human medicines committee for adults with ...
CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo
BMY obtains CHMP recommendation for Opdivo for perioperative regimen of neoadjuvant Opdivo and chemotherapy followed by ...
Halozyme: Bristol Myers receives positive CHMP opinion for Opdivo/Enhanze
Halozyme Therapeutics (HALO) announced that Bristol Myers Squibb (BMY) received a positive opinion from the Committee for Medicinal Products ...
Healio3d
Neoadjuvant immunotherapy may improve outcomes in high-risk breast cancer
The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among certain ...
Pharmabiz4d
EMA committee recommends approval of Bristol Myers Squibb’s subcutaneous formulation of Opdivo across multiple solid tumour indications
EMA committee recommends approval of Bristol Myers Squibb’s subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Monday, March 31, ...
CURE4d
First Patient Dosed in Trial of [212Pb]VMT01 for Metastatic Melanoma
The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with ...
CURE4d
What Patients With Kidney Cancer Need to Know From ASCO GU
There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.
Medical Dialogues5d
Bristol Myers Squibb receives positive EMA Committee opinion for Perioperative Opdivo plus Chemo in Resectable Non-Small Cell Lung Cancer plus PD-L1
Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
SA Asks: What are the best large-cap cardiology stocks right now?
What are the best large-cap cardiology pharmaceutical, biotech and medtech stocks to invest in right now? Seeking Alpha ...
Medical Dialogues5d
Bristol Myers Squibb gets Positive EMA Committee opinion for subcutaneous formulation of Opdivo across Multiple Solid Tumor Indications
Princeton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...
Why Bristol-Myers Squibb Co. (BMY) Went Up On Friday?
We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a ...